Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | GLS | O94925 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30523037 | 1.00 | CA12 (0.59) | CA12CA9ALDH1A1GLSKDM4E | |
| Fluoride SCHEMBL28030878 | 0.98 | CA12 (0.57) | CA12CA9ALDH1A1GLSKDM4E | |
| Phthalimide SCHEMBL9325863 | 0.88 | GSK3B (0.58) | CA12CA9ALDH1A1GLSKDM4E | |
| Phthalimide SCHEMBL7428438 | 0.86 | GSK3B (0.56) | CA12CA9ALDH1A1GLSKDM4E | |
| SCHEMBL5173987 | 0.85 | CA12 (0.50) | CA12CA9ALDH1A1GLSKDM4E | |
| SCHEMBL10948710 | 0.85 | CA12 (0.50) | CA12CA9ALDH1A1GLSKDM4E | |
| SCHEMBL11841551 | 0.84 | KDM4E (0.50) | CA12CA9ALDH1A1GLSKDM4E | |
| SCHEMBL9344497 | 0.82 | HEXA (0.46) | CA12CA9ALDH1A1KDM4EMAPT | |
| SCHEMBL29514557 | 0.81 | HEXA (0.69) | CA12CA9ALDH1A1GLSKDM4E | |
| SCHEMBL64902 | 0.81 | HEXA (0.69) | CA12CA9ALDH1A1GLSKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1563 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059805-A | Method for preparing electronic grade isopropanol | 中国石油化工股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-121155358-B | Ultrafiltration membrane, preparation method thereof and application of ultrafiltration membrane in pure water treatment | 深圳市纯水一号科技股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122060105-A | Chelate resin and preparation method thereof, and method for preparing electronic grade isopropanol | 中国石油化工股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260125341-A1 | METHODS FOR SYNTHESIZING AND PURIFYING AMINOALKYL TETRACYCLINE COMPOUNDS | PARATEK PHARM INNC (US) | 2026-05-07 | — | — | US | claimed |
| WO-2025094187-A1 | A SINGLE STEP PROCESS FOR THE PREPARATION OF OMADACYCLINE TOSYLATE OF FORMULA (X) | SUMAR BIOTECH LLP (IN) | 2025-05-08 | — | — | WO | claimed |
| CN-119841739-A | Preparation method of 7-demethylo Ma Huansu | 重庆常捷医药有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119792998-A | Composite solvent for separating high-carbon-end olefin and internal olefin and use method thereof | 天津海成能源工程技术有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-222605433-U | Aromatic hydrocarbon separation device | 天津海成能源工程技术有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119528791-A | Method for recovering N-hydroxymethyl phthalimide from 4-AA key intermediate residues | 山东汇海医药化工有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119143767-A | Phthalimide phthalocyanine derivative, preparation method thereof, pigment composition and application | 山东凯瑞尔光电科技有限公司 | 2024-12-17 | — | — | CN | claimed |
| EP-0180812-B1 | 3,6 BIS(SUBSTITUTED) ACRIDINE DERIVATIVES | AMERICAN CYANAMID COMPANY (US) | 1991-05-15 | — | — | EP | claimed |
| US-4952608-A | CONTROLLING PH TO IMPROVE STABILITY | BAYER AKTIENGESELLSCHAFT (DE) | 1990-08-28 | — | — | US | claimed |
| US-4950770-A | Psoralens aminomethylation | ELDER PHARMACEUTICALS, INC. (US) | 1990-08-21 | — | — | US | claimed |
| EP-0309861-A2 | Process for the manufacture of synthetic resins having anionic exchange properties | BAYER AG (DE) | 1989-04-05 | — | — | EP | claimed |
| EP-0180812-A2 | 3,6 Bis(substituted) acridine derivatives | AMERICAN CYANAMID COMPANY (US) | 1986-05-14 | — | — | EP | claimed |
| US-4423243-A | Process for the preparation of 2,2-dimethyl-3-vinyl-cyclopropanecarboxylic acids and esters | BAYER AKTIENGESELLSCHAFT (DE) | 1983-12-27 | — | — | US | claimed |
| US-4347371-A | HYPERTENSIVE AGENTS; ANTIDIABETIC AGENTS; VISION DEFECTS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1982-08-31 | — | — | US | claimed |
| EP-0055219-A1 | Dyestuffs, their preparation and use | CIBA-GEIGY AG (CH) | 1982-06-30 | — | — | EP | claimed |
| EP-0031104-A1 | Thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1981-07-01 | — | — | EP | claimed |
| US-4013685-A | PROCESS FOR THE MANUFACTURE OF N(MERCAPTOMETHYL) PHTHALIMIDE S-(O,O-DIMETHYL PHOSPHORODITHIOATE | STAUFFER CHEMICAL COMPANY (US) | 1977-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125341-A1 | METHODS FOR SYNTHESIZING AND PURIFYING AMINOALKYL TETRACYCLINE COMPOUNDS | TET1, TET3, IL4I1 | CA12 3132/4885CA9 713/4885ALDH1A1 3938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.